Twelve healthy adults ( 6 men and 6 women ) with body mass index of 35.7 2.9 kg/m ( 2 ) ( mean SD ) received RM-493 ( 1 mg/24 h ) or placebo by continuous subcutaneous infusion over 72 hours , followed immediately by crossover to the alternate treatment .